Back HIV Prevention Treatment as Prevention

Treatment as Prevention

AIDS 2016: SEARCH Study Exceeds 90-90-90 Targets After 2 Years of HIV Test-and-Treat

A large study that embeds "'test-and-treat" for HIV within a larger multi-disease prevention campaign in rural Kenya and Uganda has achieved 82% viral suppression after 2 years, and has already exceeded UNAIDS targets for viral suppression after 1 year of activity, investigators from the SEARCH study reported at the 21st International AIDS Conference (AIDS 2016) this week in Durban.

alt

Read more:

HIV Treatment Reduces HIV Transmission by 77% among South African Couples

Antiretroviral treatment reduced the risk of HIV transmission by 77% in serodiscordant couples in rural South Africa, a population-based study carried out in the province of KwaZulu-Natal has shown. The findings were recently published in the advance online edition of Clinical Infectious Diseases. The investigators say that their findings provide a real-life estimate of the impact of antiretroviral treatment on HIV transmission under normal community conditions.

alt

Read more:

IAPAC Summit: At Least 25,000 People in the U.S. May Now Be Using PrEP

As many as 30,000 people in the U.S. may now be taking pre-exposure prophylaxis (PrEP) to prevent HIV, researchers reported at the 4th IAPAC Controlling the HIV Epidemic with Antiretrovirals summit in Paris last week. Meanwhile, as the summit also heard, European and other countries face frustrating delays in securing access to PrEP.

alt

Read more:

IAPAC Summit: How Do We Treat the World? Experts Discuss Moving to Universal HIV Treatment

What practical steps does the global healthcare community need to take in order to expand HIV treatment so that it can reach everyone who is diagnosed? And how do we expand testing so that as many HIV-positive people as possible are diagnosed, on treatment, and virally suppressed? These were the themes of the discussion concerning what used to be called "Treatment as Prevention" at the recent 2015 IAPAC Controlling the HIV Epidemic with Antiretrovirals summit in Paris.

alt

Read more:

U.S. Physicians Routinely Offer Early HIV Treatment, But Only a Third Have Prescribed PrEP

Most doctors at the frontline of the HIV epidemic in the United States recommend early antiretroviral therapy (ART) and many also believe they have a role in providing pre-exposure prophylaxis (PrEP) to the uninfected partners of their patients living with HIV, according to research published in the online edition of Clinical Infectious Diseases. Overall, 87% of doctors recommended ART from the point of diagnosis and most thought PrEP was appropriate in some circumstances. However, only a third had actually prescribed PrEP.

alt

Read more: